Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging

被引:114
作者
Eckert, T
Sailer, M
Kaufmann, J
Schrader, C
Peschel, T
Bodammer, N
Heinze, HJ
Schoenfeld, MA
机构
[1] Univ Magdeburg, Dept Neurol 2, D-39120 Magdeburg, Germany
[2] Hannover Med Sch, Dept Neurol & Clin Neurophysiol, D-30625 Hannover, Germany
关键词
multiple system atrophy; magnetization transfer imaging; Parkinson's disease;
D O I
10.1016/j.neuroimage.2003.08.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The differentiation of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) from idiopathic Parkinson's disease (IPD) is difficult. Magnetization transfer imaging (MTI), a measure that correlates with myelination and axonal density, was employed in this study in the attempt to distinguish between these disorders. Measurements were carried out in 15 patients with IPD, 12 patients with MSA, 10 patients with PSP, and in 20 aged-matched healthy control subjects. The main finding was a change in the magnetization transfer ratio in the globus pallidus, putamen, caudate nucleus, substantia nigra, and white matter in IPD, MSA, and PSP patients, matching the pathological features of the underlying disorder. Furthermore, stepwise linear discriminant analysis provided a good classification of the individual patients into the different disease groups. All IPD patients and control subjects were correctly separated from the MSA and PSP cohort, and all PSP patients and 11 of 12 MSA patients were correctly separated from the IPD and control cohort. There was also a fairly good discrimination of IPD patients from control subjects and of MSA from PSP patients. In conclusion, MTI revealed degenerative changes in patients with different parkinsonian syndromes matching the underlying pathological features of the different diseases, underlining the high potential of this method in distinguishing MSA and PSP from IPD. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 63 条
[1]  
Agid Y., 1992, PROGRESSIVE SUPRANUC, P254
[2]   Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET [J].
Antonini, A ;
Kazumata, K ;
Feigin, A ;
Mandel, F ;
Dhawan, V ;
Margouleff, C ;
Eidelberg, D .
MOVEMENT DISORDERS, 1998, 13 (02) :268-274
[3]   Steele-Richardson-Olszewski syndrome:: Reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo:: 123IBZM SPECT and MRI study [J].
Arnold, G ;
Tatsch, K ;
Kraft, E ;
Oertel, WH ;
Schwarz, J .
MOVEMENT DISORDERS, 2002, 17 (03) :557-562
[4]   Echogenicity of the substantia nigra in Parkinsons disease and its relation to clinical findings [J].
Berg, D ;
Siefker, C ;
Becker, G .
JOURNAL OF NEUROLOGY, 2001, 248 (08) :684-689
[5]   DIFFERING PATTERNS OF STRIATAL F-18 DOPA UPTAKE IN PARKINSONS-DISEASE, MULTIPLE SYSTEM ATROPHY, AND PROGRESSIVE SUPRANUCLEAR PALSY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
QUINN, N ;
LEES, AJ ;
MATHIAS, CJ ;
BANNISTER, R ;
MARSDEN, CD ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1990, 28 (04) :547-555
[6]   STRIATAL D2 RECEPTOR STATUS IN PATIENTS WITH PARKINSONS-DISEASE, STRIATONIGRAL DEGENERATION, AND PROGRESSIVE SUPRANUCLEAR PALSY, MEASURED WITH C-11 RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
PLAYFORD, ED ;
QUINN, N ;
MATHIAS, CJ ;
LEES, AJ ;
MARSDEN, CD ;
BANNISTER, R ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1992, 31 (02) :184-192
[7]   Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moya [J].
Chabbert, V ;
Ranjeva, JP ;
Sevely, A ;
Boetto, S ;
Berry, I ;
Manelfe, C .
NEURORADIOLOGY, 1998, 40 (04) :267-271
[8]  
DANIELSEN ER, 1998, BASIC PHYS MRS MAGNE, P5
[9]   SUBCORTICAL DEMENTIA - FRONTAL-CORTEX HYPOMETABOLISM DETECTED BY POSITRON TOMOGRAPHY IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY [J].
DANTONA, R ;
BARON, JC ;
SAMSON, Y ;
SERDARU, M ;
VIADER, F ;
AGID, Y ;
CAMBIER, J .
BRAIN, 1985, 108 (SEP) :785-799
[10]   DIFFERENTIATION OF MULTIPLE SYSTEM ATROPHY FROM IDIOPATHIC PARKINSONS-DISEASE USING PROTON MAGNETIC-RESONANCE SPECTROSCOPY [J].
DAVIE, CA ;
WENNING, GK ;
BARKER, GJ ;
TOFTS, PS ;
KENDALL, BE ;
QUINN, N ;
MCDONALD, WI ;
MARSDEN, CD ;
MILLER, DH .
ANNALS OF NEUROLOGY, 1995, 37 (02) :204-210